Charles L. Shapiro, MD, a renowned breast cancer researcher and clinician, has been named Co-Director of the Dubin Breast Center, Director of Translational Breast Cancer Research for the Mount Sinai Health System, and Director of Survivorship Programs at The Tisch Cancer Institute at Mount Sinai.

“As a nationally recognized leader in breast medical oncology and research, Dr. Shapiro will have a pivotal role in advancing breast cancer treatment and care for our patients,” says Elisa Port, MD, Chief of Breast Surgery and Co-Director of the Dubin Breast Center at The Tisch Cancer Institute.

He joins Mount Sinai from The Ohio State University Comprehensive Cancer Center, where he was Section Chief of Breast Cancer, Breast Research Program Leader, and Director of Breast Medical Oncology.

“Dr. Shapiro’s research interest spans the whole patient,” says William Oh, MD, Associate Director of Clinical Research at The Tisch Cancer Institute, Chief of the Division of Hematology/Medical Oncology, and the Ezra M. Greenspan, MD, Professor in Clinical Cancer Therapeutics. “It begins with understanding the molecular drivers of cancer and treating cancers more effectively, and then monitoring the side effects of treatment.”

Dr. Shapiro will establish a large unified breast cancer research program across the Health System, which will include innovative clinical trials and the collection of breast tissues for a central breast tissue biorepository. “Mount Sinai has exceptional basic and population scientists devoted to breast cancer, and within the Health System there are outstanding breast cancer clinical researchers,” says Dr. Shapiro. “I intend to facilitate more interactions and collaborations between these two groups to hasten discoveries into the clinic for women with breast cancer.”